8-K

Company

Inhibitor Therapeutics, Inc.

Filed

November 5, 2018

Period of Report

November 5, 2018

Accession Number

0001193125-18-318466

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →